
Cancer is not a pleasant topic. In developed countries, every sixth death is already attributable to it, and often even in younger people. However, new and innovative therapies are providing significantly improved survival rates and a significantly extended life expectancy for patients. In the Bio-Pharma segment Oncology, sales of over USD 200 billion were recorded in 2023. By 2028 [...]
Life Sciences: What opportunities does the booming oncology market offer investors?
